Cassava Sciences, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cassava Sciences, Inc. (SAVA)
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Cassava Sciences, Inc. for potential securities fraud following the company's announcement that its Phase 3 ReThink-ALZ study did not meet key endpoints.
December 05, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cassava Sciences is under investigation by Levi & Korsinsky for potential securities fraud after its Phase 3 Alzheimer's study failed to meet key endpoints.
The investigation by Levi & Korsinsky into potential securities fraud is likely to negatively impact investor confidence in Cassava Sciences. The failure of the Phase 3 study to meet endpoints adds to the negative sentiment, potentially leading to a decline in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100